Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gini F Fleming

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Cancer Chemotherapy and Pharmacology|August 13, 2002
Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairmentChetan Lathia, Gini F Fleming, Mark Meyer, et al.
Frontiers in Oncology|April 6, 2016
The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 YearsSteven J Gibson, Gini F Fleming, Sarah M Temkin, et al.
Gynecologic Oncology Reports|August 9, 2021
Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumabMeng Wu, Jennifer A Bennett, Pankti Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and ShadowsMeredith M Regan, Gini F Fleming, Barbara Walley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2019
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancerJennifer Taylor Veneris, Lei Huang, Jane E Churpek, et al.
Gynecologic Oncology|February 27, 2004
Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignanciesArno J Mundt, Jacob Rotmensch, Steven E Waggoner, et al.
Ebiomedicine|July 3, 2015
Nanomedicine for Combination Therapy of CancerChunbai He, Christina Chan, Ralph R Weichselbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Reply to F. Tomao et alKarin Ribi, Jürg Bernhard, Weixiu Luo, et al.
The American Journal of Surgical Pathology|December 23, 2025
A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and Consequences of Tumor Mutational BurdenAnusha Vemuri, Melissa Y Tjota, Pankhuri Wanjari, et al.
CA: a Cancer Journal for Clinicians|January 25, 2022
Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancerJennifer A Bennett, Gini F Fleming, Katherine C Kurnit, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Cancer Chemotherapy and Pharmacology|August 13, 2002
Pentostatin pharmacokinetics and dosing recommendations in patients with mild renal impairmentChetan Lathia, Gini F Fleming, Mark Meyer, et al.
Frontiers in Oncology|April 6, 2016
The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 YearsSteven J Gibson, Gini F Fleming, Sarah M Temkin, et al.
Gynecologic Oncology Reports|August 9, 2021
Successful treatment of squamous cell carcinoma arising from a presumed ovarian mature cystic teratoma with pembrolizumabMeng Wu, Jennifer A Bennett, Pankti Reid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and ShadowsMeredith M Regan, Gini F Fleming, Barbara Walley, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2019
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancerJennifer Taylor Veneris, Lei Huang, Jane E Churpek, et al.
Gynecologic Oncology|February 27, 2004
Phase I trial of concomitant vinorelbine, cisplatin, and pelvic irradiation in cervical carcinoma and other advanced pelvic malignanciesArno J Mundt, Jacob Rotmensch, Steven E Waggoner, et al.
Ebiomedicine|July 3, 2015
Nanomedicine for Combination Therapy of CancerChunbai He, Christina Chan, Ralph R Weichselbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2016
Reply to F. Tomao et alKarin Ribi, Jürg Bernhard, Weixiu Luo, et al.
The American Journal of Surgical Pathology|December 23, 2025
A Deeper Dive into POLE-Mutated Endometrial Carcinomas: The Contributions and Consequences of Tumor Mutational BurdenAnusha Vemuri, Melissa Y Tjota, Pankhuri Wanjari, et al.
CA: a Cancer Journal for Clinicians|January 25, 2022
Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancerJennifer A Bennett, Gini F Fleming, Katherine C Kurnit, et al.
Pageof 18